| 000 | 00836 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250512161452.0 | ||
| 264 | 0 | _c19700810 | |
| 008 | 197008s 0 0 eng d | ||
| 022 | _a0003-0465 | ||
| 024 | 7 |
_a10.1016/s0003-0465(16)31258-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGriffenhagen, G B | |
| 245 | 0 | 0 |
_aCritical thinkers and thinking critics. _h[electronic resource] |
| 260 |
_bJournal of the American Pharmaceutical Association _cJun 1970 |
||
| 300 |
_a301 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 | _aPharmacists |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 773 | 0 |
_tJournal of the American Pharmaceutical Association _gvol. 10 _gno. 6 _gp. 301 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0003-0465(16)31258-7 _zAvailable from publisher's website |
| 999 |
_c5424617 _d5424617 |
||